Contact
Please use this form to send email to PR contact of this press release:
ROSEN, GLOBAL INVESTOR RIGHTS COUNSEL, Encourages Zenas BioPharma, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – ZBIO
TO: